Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cartron, P.-F.
Right arrow Articles by Vallette, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cartron, P.-F.
Right arrow Articles by Vallette, F. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 6 675-687
© 2002 Oxford University Press

The expression of a new variant of the pro-apoptotic molecule Bax, Bax{psi}, is correlated with an increased survival of glioblastoma multiforme patients

Pierre-François Cartron1, Lisa Oliver1, Stéphane Martin1,2, Carole Moreau1, Marie-Thérèse LeCabellec1, Pascal Jezequel3, Khaled Meflah1 and François M. Vallette1,+

1IFR 26, INSERM UMR 419, 9 quai Moncousu, 44035 Nantes Cedex 01, France, 2Clinique Universitaire de Neurochirurgie, Hôpital G and R Laennec, CHU Nantes, Bld J. Monod-St Herblain, 44093 Nantes Cedex 01, France and 3Centre René Gauducheau, Bld J. Monod-St Herblain, 44093 Nantes Cedex 01, France

Pro- and anti-apoptotic members of the BCL-2 family play a central role in the implementation of apoptosis. Bax, a pro-apoptotic member of this family, has as such been considered as a potential tumor suppressor. Here, we have examined the expression of Bax in 55 patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain tumors. We report on the existence of a new form of Bax, present in 24% of the patients, which we called Bax{psi}. Bax{psi} is a N-terminal truncated form of Bax which results from a partial deletion of the exon 1 of Bax gene. Bax{psi} and the wild-type form, Bax{alpha}, are encoded by distinct mRNAs, both of which are present in normal tissues. Glial tumors express either Bax{alpha} or Bax{psi} proteins, an apparent consequence of an exclusive transcription of the corresponding mRNAs. The latter feature could be partially linked to distinct methylation profiles of Bax gene in these tumors. The Bax{psi} protein is preferentially localized to mitochondria and is a more powerful inducer of apoptosis than Bax{alpha}. Bax{psi} tumors exhibit a slow proliferation in Swiss nude mice and this feature can be circumvented by the co-expression of the Bcl-2 transgene, the functional antagonist of Bax. More importantly, the expression of Bax{psi} correlates with a longer survival in patients (18 months versus 10 months for Bax{alpha} patients). Thus, our results provide the first indication of a beneficial involvement of a variant of the pro-apoptotic protein Bax in tumor progression.

+ To whom correspondence should be addressed. Tel: +33 24 0084081; Fax: +33 24 0084082; Email: fval@nantes.inserm.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
F. Manero, F. Gautier, T. Gallenne, N. Cauquil, D. Gree, P.-F. Cartron, O. Geneste, R. Gree, F. M. Vallette, and P. Juin
The Small Organic Compound HA14-1 Prevents Bcl-2 Interaction with Bax to Sensitize Malignant Glioma Cells to Induction of Cell Death.
Cancer Res., March 1, 2006; 66(5): 2757 - 2764.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
A. Aouacheria, F. Brunet, and M. Gouy
Phylogenomics of Life-Or-Death Switches in Multicellular Animals: Bcl-2, BH3-Only, and BNip Families of Apoptotic Regulators
Mol. Biol. Evol., December 1, 2005; 22(12): 2395 - 2416.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-F. Cartron, H. Arokium, L. Oliver, K. Meflah, S. Manon, and F. M. Vallette
Distinct Domains Control the Addressing and the Insertion of Bax into Mitochondria
J. Biol. Chem., March 18, 2005; 280(11): 10587 - 10598.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Poncet, N. Larochette, A.-L. Pauleau, P. Boya, A.-A. Jalil, P.-F. Cartron, F. Vallette, C. Schnebelen, L. M. Bartle, A. Skaletskaya, et al.
An Anti-apoptotic Viral Protein That Recruits Bax to Mitochondria
J. Biol. Chem., May 21, 2004; 279(21): 22605 - 22614.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P.-F. Cartron, P. Juin, L. Oliver, S. Martin, K. Meflah, and F. M. Vallette
Nonredundant Role of Bax and Bak in Bid-Mediated Apoptosis
Mol. Cell. Biol., July 1, 2003; 23(13): 4701 - 4712.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Moreau, P.-F. Cartron, A. Hunt, K. Meflah, D. R. Green, G. Evan, F. M. Vallette, and P. Juin
Minimal BH3 Peptides Promote Cell Death by Antagonizing Anti-apoptotic Proteins
J. Biol. Chem., May 23, 2003; 278(21): 19426 - 19435.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P.-F. Cartron, M. Priault, L. Oliver, K. Meflah, S. Manon, and F. M. Vallette
The N-terminal End of Bax Contains a Mitochondrial-targeting Signal
J. Biol. Chem., March 21, 2003; 278(13): 11633 - 11641.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. McIlroy, P.-F. Cartron, P. Tuffery, Y. Dudoit, A. Samri, B. Autran, F. M. Vallette, P. Debre, and I. Theodorou
A triple-mutated allele of granzyme B incapable of inducing apoptosis
PNAS, March 4, 2003; 100(5): 2562 - 2567.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Lomonosova, T. Subramanian, and G. Chinnadurai
Requirement of BAX for Efficient Adenovirus-Induced Apoptosis
J. Virol., October 11, 2002; 76(22): 11283 - 11290.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.